Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ximeien Salicylic Acid Oil-Control Anti-Dandruff Shampoo is a medicated topical treatment formulated for the management of seborrheic dermatitis and dandruff. The primary active ingredient, salicylic acid, is a beta-hydroxy acid that functions as a keratolytic agent by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This process facilitates the shedding of dead skin cells from the scalp, thereby reducing flaking and oiliness. The product is being studied by The 2nd Affiliated Hospital of Chongqing Medical University in clinical trials to evaluate its impact on the scalp microenvironment and patient satisfaction in comparison to other treatments like ketoconazole shampoo and complex acid therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ximeien Salicylic Acid Oil-Control Anti-Dandruff Shampoo.